Display options
Cite
Haffner ME. The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases. Retina. 2005;25(8):S89-S90doi: 10.1097/00006982-200512001-00045.
Haffner, M. E. (2005). The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases. Retina (Philadelphia, Pa.), 25(8), S89-S90. https://doi.org/10.1097/00006982-200512001-00045
Haffner, Marlene E. "The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases." Retina (Philadelphia, Pa.) vol. 25,8 (2005): S89-S90. doi: https://doi.org/10.1097/00006982-200512001-00045
Haffner ME. The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases. Retina. 2005 Dec;25(8):S89-S90. doi: 10.1097/00006982-200512001-00045. PMID: 16374359.
Copy Download .nbib Format: NLM
Share it on

Retina. 2005 Dec;25(8):S89-S90. doi: 10.1097/00006982-200512001-00045.

The Food and Drug Administration's Office of Orphan Products Development: incentives, grants, and special designations speed therapies for orphan diseases.

Retina (Philadelphia, Pa.)

Marlene E Haffner

Affiliations

  1. The FDA Office of Orphan Products Development and Public Health Service, USA.

PMID: 16374359 DOI: 10.1097/00006982-200512001-00045

[No abstract available.]

MeSH terms

Publication Types